These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8150753)

  • 1. Pharmacokinetics of cefepime: a review.
    Van der Auwera P; Santella PJ
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():103-15. PubMed ID: 8150753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefepime in patients with the sepsis syndrome.
    Kieft H; Hoepelman AI; Knupp CA; van Dijk A; Branger JM; Struyvenberg A; Verhoef J
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():117-22. PubMed ID: 8150754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects.
    Barbhaiya RH; Forgue ST; Gleason CR; Knupp CA; Pittman KA; Weidler DJ; Movahhed H; Tenney J; Martin RR
    Antimicrob Agents Chemother; 1992 Mar; 36(3):552-7. PubMed ID: 1622165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition kinetics, bioavailability and renal clearance of cefepime in calves.
    Ismail MM
    Vet Res Commun; 2005 Jan; 29(1):69-79. PubMed ID: 15727293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes.
    Ismail M
    J Vet Pharmacol Ther; 2005 Dec; 28(6):499-503. PubMed ID: 16343281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the pharmacokinetics of cefepime in children.
    Blumer JL; Reed MD; Knupp C
    Pediatr Infect Dis J; 2001 Mar; 20(3):337-42. PubMed ID: 11303847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers.
    Bächer K; Schaeffer M; Lode H; Nord CE; Borner K; Koeppe P
    J Antimicrob Chemother; 1992 Sep; 30(3):365-75. PubMed ID: 1452502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, tolerance, and pharmacokinetics of cefepime administered intramuscularly to healthy subjects.
    Barbhaiya RH; Knupp CA; Tenney J; Martin RR; Weidler DJ; Pittman KA
    J Clin Pharmacol; 1990 Oct; 30(10):900-10. PubMed ID: 2229450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-proportional pharmacokinetics of cefepime in rats.
    Brindley CJ; Brodie RR; Cook SC; Oldfield PR; Chasseaud LF; Barbhaiya RH
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():9-14. PubMed ID: 1820942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children.
    Reed MD; Yamashita TS; Knupp CK; Veazey JM; Blumer JL
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1783-7. PubMed ID: 9257761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics, safety, and tolerance of cefepime administered as an intravenous bolus or as a rapid infusion.
    Garrelts JC; Wagner DJ
    Ann Pharmacother; 1999 Dec; 33(12):1258-61. PubMed ID: 10630824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of cefepime in cystic fibrosis patients.
    Huls CE; Prince RA; Seilheimer DK; Bosso JA
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1414-6. PubMed ID: 8363368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefepime in patients with thermal burn injury.
    Bonapace CR; White RL; Friedrich LV; Norcross ED; Bosso JA
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2848-54. PubMed ID: 10582870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of cefepime in patients undergoing continuous ambulatory peritoneal dialysis.
    Barbhaiya RH; Knupp CA; Pfeffer M; Zaccardelli D; Dukes GM; Mattern W; Pittman KA; Hak LJ
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1387-91. PubMed ID: 1510432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses.
    Barbhaiya RH; Forgue ST; Gleason CR; Knupp CA; Pittman KA; Weidler DJ; Martin RR
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1118-22. PubMed ID: 2203303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and tissue penetration of cefepime.
    Nye KJ; Shi YG; Andrews JM; Wise R
    J Antimicrob Chemother; 1989 Jul; 24(1):23-8. PubMed ID: 2777727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of age and gender on pharmacokinetics of cefepime.
    Barbhaiya RH; Knupp CA; Pittman KA
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1181-5. PubMed ID: 1416818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.